Blood levels do not predict behavioral or physiological effects of Δ9-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure

被引:17
作者
Ginsburg, Brett C. [1 ,2 ]
Hruba, Lenka [1 ]
Zaki, Armia [1 ]
Javors, Martin A. [1 ,2 ]
McMahon, Lance R. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA
关键词
Marijuana; 11-OH-THC; THC-COOH; Rhesus; Legal limit; Driving under the influence; DUI; ACUTE TOLERANCE; CHRONIC DELTA-9-TETRAHYDROCANNABINOL; SMOKED CANNABIS; CROSS-TOLERANCE; PERFORMANCE; PLASMA; THC; HEAVY; USERS; RATS;
D O I
10.1016/j.drugalcdep.2014.02.696
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Recent changes in the legality of cannabis have prompted evaluation of whether blood levels of Delta(9)-tetrahydrocannabinol (THC) or its metabolites could be used to substantiate impairment, particularly related to behavioral tasks such as driving. However, because marked tolerance develops to behavioral effects of THC, the applicability of a particular threshold of blood THC as an index of impairment in people with different patterns of use remains unclear. Studies relevant to this issue are difficult to accomplish in humans, as prior drug exposure is difficult to control. Methods: Here, effects of THC to decrease rectal temperature and operant response rate compared to levels of THC and its metabolites were studied in blood in two groups of monkeys: one received intermittent treatment with THC (0.1 mg/kg i.v. every 3-4 days) and another received chronic THC (1 mg/kg/12 h s.c.) for several years. Results: In monkeys with intermittent THC exposure, a single dose of THC (3.2 mg/kg s.c.) decreased rectal temperature and response rate. The same dose did not affect response rate or rectal temperature in chronically exposed monkeys, indicative of greater tolerance. In both groups, blood levels of THC peaked 20-60 min post-injection and had a similar half-life of elimination, indicating no tolerance to the pharmacokinetics of THC. Notably, in both groups, the behavioral effects of THC were not apparent when blood levels were maximal (20-min post-administration). Conclusion: These data indicate that thresholds for blood levels of THC do not provide a consistent index of behavioral impairment across individuals with different patterns of THC exposure. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 48 条
  • [11] JWH-018 and JWH-073: Δ9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects in Monkeys
    Ginsburg, Brett C.
    Schulze, David R.
    Hruba, Lenka
    McMahon, Lance R.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (01) : 37 - 45
  • [12] Developing limits for driving under cannabis
    Grotenhermen, Franjo
    Leson, Gero
    Berghaus, Guenter
    Drummer, Olaf H.
    Krueger, Hans-Peter
    Longo, Marie
    Moskowitz, Herbert
    Perrine, Bud
    Ramaekers, Johannes G.
    Smiley, Alison
    Tunbridge, Rob
    [J]. ADDICTION, 2007, 102 (12) : 1910 - 1917
  • [13] Hartman H., 2013, Employee Relations Law Journal, V38, P72
  • [14] Cannabis Effects on Driving Skills
    Hartman, Rebecca L.
    Huestis, Marilyn A.
    [J]. CLINICAL CHEMISTRY, 2013, 59 (03) : 478 - 492
  • [15] ACUTE AND CHRONIC ETHANOL TOLERANCE - OPERANT-BEHAVIOR IN NAIVE AND ETHANOL TOLERANT RATS
    HILTUNEN, AJ
    JARBE, TUC
    [J]. PSYCHOPHARMACOLOGY, 1992, 107 (04) : 511 - 516
  • [16] DO PLASMA-CONCENTRATIONS OF DELTA-9-TETRAHYDROCANNABINOL REFLECT THE DEGREE OF INTOXICATION
    HOLLISTER, LE
    GILLESPIE, HK
    OHLSSON, A
    LINDGREN, JE
    WAHLEN, A
    AGURELL, S
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) : S171 - S177
  • [17] Apparent Inverse Relationship between Cannabinoid Agonist Efficacy and Tolerance/Cross-Tolerance Produced by Δ9-Tetrahydrocannabinol Treatment in Rhesus Monkeys
    Hruba, Lenka
    Ginsburg, Brett C.
    McMahon, Lance R.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) : 843 - 849
  • [18] Huestis MA, 2005, HANDB EXP PHARMACOL, V168, P657
  • [19] Relationship of Δ9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis
    Huestis, MA
    Cone, EJ
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (06) : 394 - 399
  • [20] Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC
    Hunault, Claudine C.
    Mensinga, Tjeert T.
    de Vries, Irma
    Kelholt-Dijkman, Hermien H.
    Hoek, Jani
    Kruidenier, Maaike
    Leenders, Marianne E. C.
    Meulenbelt, Jan
    [J]. PSYCHOPHARMACOLOGY, 2008, 201 (02) : 171 - 181